Louisiana Pharmacies' Availability of Emergency Contraception and Counseling Accuracy to Adolescent and Physician Callers.


Journal

Journal of pediatric and adolescent gynecology
ISSN: 1873-4332
Titre abrégé: J Pediatr Adolesc Gynecol
Pays: United States
ID NLM: 9610774

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 11 12 2020
revised: 29 01 2021
accepted: 14 02 2021
pubmed: 26 2 2021
medline: 26 11 2021
entrez: 25 2 2021
Statut: ppublish

Résumé

Adolescents face many barriers to obtaining emergency contraception (EC), despite it being an approved and recommended method to prevent unintended pregnancy. This study examined pharmacy-related barriers to adolescents' access to EC in Louisiana. Prospective, telephone-call secret shopper study to pharmacies to assess same-day EC availability and barriers to purchase. A total of 182 pharmacies in 5 Louisiana cities. Responses provided by pharmacists or other pharmacy staff assessed between July 2018 and November 2019. Collected data from secret shopper phone calls and compared responses provided to callers between male and female callers and physician and adolescent callers. Same-day levonorgestrel (LNG) availability, same-day ulipristal acetate (UPA) availability, age restrictions on purchase, requirement of parental consent for purchase, and type of staff member that advised the caller. Of 364 calls to 182 pharmacies, 66% of pharmacists or other pharmacy staff reported same-day LNG access and 5% reported same-day UPA access. An inaccurate age restriction regarding EC purchase was reported in 15% of calls. Female callers were cited this age restriction more frequently than their male counterparts (20% vs 10%). Pharmacists were more likely than other pharmacy staff to counsel female callers compared to male callers (52% vs 27%) and physician callers compared to adolescents (50% vs 30%). Many pharmacies in Louisiana have limited same-day availability of EC and often report inconsistent and inaccurate age and consent regulations for its use. Continued outreach and education to pharmacies is necessary to address these barriers to adolescent EC access.

Identifiants

pubmed: 33631348
pii: S1083-3188(21)00146-7
doi: 10.1016/j.jpag.2021.02.102
pii:
doi:

Substances chimiques

Contraceptives, Postcoital 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

693-698

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Nikka Khorsandi (N)

Louisiana State University Health Sciences Center, School of Medicine, New Orleans, Louisiana. Electronic address: nkhors@lsuhsc.edu.

Elvira Chiccarelli (E)

Department of Pediatrics, Louisiana State University Health Sciences Center, New Orleans, Louisiana.

S Amanda Dumas (SA)

Department of Pediatrics, Louisiana State University Health Sciences Center, New Orleans, Louisiana.

Ryan H Pasternak (RH)

Department of Pediatrics, Louisiana State University Health Sciences Center, New Orleans, Louisiana.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH